Question 1

Is my child eligible for this trial based on their current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection clinical trial (NCT00162227). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of the oral liquid Efavirenz?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection clinical trial (NCT00162227). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection clinical trial (NCT00162227). Contact the study team or your healthcare provider for specific answers.

Question 4

What is the process for participating in this trial, including visits and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection clinical trial (NCT00162227). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this treatment affect my child's overall care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection clinical trial (NCT00162227). Contact the study team or your healthcare provider for specific answers.

What this study is about